posted on 2023-03-20, 17:35authored byNafsika Forte, Dustin Dovala, Matthew J. Hesse, Jeffrey M. McKenna, John A. Tallarico, Markus Schirle, Daniel K. Nomura
Targeted protein degradation (TPD) with proteolysis targeting
chimeras
(PROTACs), heterobifunctional compounds consisting of protein targeting
ligands linked to recruiters of E3 ubiquitin ligases, has arisen as
a powerful therapeutic modality to induce the proximity of target
proteins with E3 ligases to ubiquitinate and degrade specific proteins
in cells. Thus far, PROTACs have primarily exploited the recruitment
of E3 ubiquitin ligases or their substrate adapter proteins but have
not exploited the recruitment of more core components of the ubiquitin-proteasome
system (UPS). In this study, we used covalent chemoproteomic approaches
to discover a covalent recruiter against the E2 ubiquitin conjugating
enzyme UBE2DEN67that targets an allosteric cysteine,
C111, without affecting the enzymatic activity of the protein. We
demonstrated that this UBE2D recruiter could be used in heterobifunctional
degraders to degrade neo-substrate targets in a UBE2D-dependent manner,
including BRD4 and the androgen receptor. Overall, our data highlight
the potential for the recruitment of core components of the UPS machinery,
such as E2 ubiquitin conjugating enzymes, for TPD, and underscore
the utility of covalent chemoproteomic strategies for identifying
novel recruiters for additional components of the UPS.